Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ceftobiprole: Phase III data

In a Phase III trial in CAP patients requiring hospitalization, ceftobiprole met the primary endpoint of non-inferiority

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE